Fig. 2From: Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosisPlot chart showing the a O-glycosylation and b N-glycosylation sites amount in 49 vaccine candidate antigensBack to article page